These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 3683786

  • 1. Pharmacodynamic evaluation of human cerebral arteries in the genesis of vasospasm.
    White RP, Robertson JT.
    Neurosurgery; 1987 Oct; 21(4):523-31. PubMed ID: 3683786
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the inhibitory effects of antithrombin III, alpha 2-macroglobulin, and thrombin in human basilar arteries: relevance to cerebral vasospasm.
    White RP.
    J Cereb Blood Flow Metab; 1987 Feb; 7(1):68-73. PubMed ID: 2433298
    [Abstract] [Full Text] [Related]

  • 3. Pharmacodynamic study of maturation and closure of human umbilical arteries.
    White RP.
    Am J Obstet Gynecol; 1989 Jan; 160(1):229-37. PubMed ID: 2912087
    [Abstract] [Full Text] [Related]

  • 4. Role of plasmin, thrombin, and antithrombin III as etiological factors in delayed cerebral vasospasm.
    White RP, Robertson JT.
    Neurosurgery; 1985 Jan; 16(1):27-35. PubMed ID: 2579347
    [Abstract] [Full Text] [Related]

  • 5. Cerebral arterial spasm. 1. In vitro contractile activity of vasoactive agents on canine basilar and middle cerebral arteries.
    Allen GS, Henderson LM, Chou SN, French LA.
    J Neurosurg; 1974 Apr; 40(4):433-41. PubMed ID: 4360691
    [No Abstract] [Full Text] [Related]

  • 6. [Cerebral vasospasm: comparison of contractile responses in isolated human and canine basilar arteries].
    Tanishima T.
    No To Shinkei; 1983 Apr; 35(4):323-9. PubMed ID: 6575794
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacodynamic effects of tosyl-arginine methyl ester (TAME) on isolated human arteries.
    White RP.
    Gen Pharmacol; 1988 Apr; 19(3):387-92. PubMed ID: 3166432
    [Abstract] [Full Text] [Related]

  • 14. Cerebrovascular sensitivity to vasoconstricting agents induced by subarachnoid hemorrhage and vasospasm in dogs.
    Toda N, Ozaki T, Ohta T.
    J Neurosurg; 1977 Mar; 46(3):296-303. PubMed ID: 839255
    [Abstract] [Full Text] [Related]

  • 15. Marked synergism between vasopressin and angiotensin II in a human isolated artery.
    Hidaka T, Tsuneyoshi I, Boyle WA, Onomoto M, Yonetani S, Hamasaki J, Katai R, Kanmura Y.
    Crit Care Med; 2005 Nov; 33(11):2613-20. PubMed ID: 16276188
    [Abstract] [Full Text] [Related]

  • 16. Prolonged exposure to oxyhemoglobin modifies the response of isolated dog middle cerebral arteries to vasoactive substances.
    Onoue H, Nakamura N, Toda N.
    Stroke; 1989 May; 20(5):657-63. PubMed ID: 2470167
    [Abstract] [Full Text] [Related]

  • 17. Neuropeptide Y: vasoconstrictor effects and possible role in cerebral vasospasm after experimental subarachnoid hemorrhage.
    Abel PW, Han C, Noe BD, McDonald JK.
    Brain Res; 1988 Nov 01; 463(2):250-8. PubMed ID: 3196916
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Cerebral vasospasm: effects of prostaglandin synthetase inhibitors in vitro.
    Chapleau CE, White RP, Robertson JT.
    Neurosurgery; 1980 Feb 01; 6(2):155-9. PubMed ID: 6767998
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.